← Open Payments lookup

JAYLIN MILLER: Open Payments

NPI 1912421553 · IOWA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$826 in 41 payments from 15 companies in 2025. Trend: 2023 $157 · 2024 $462 · 2025 $826

Food & beverage: $826
CompanyPaymentsAmount
ABBVIE INC.12$155
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$142
Takeda Pharmaceuticals U.S.A., Inc.6$126
PFIZER INC.3$88
Axsome Therapeutics, Inc.4$81
AstraZeneca Pharmaceuticals LP2$44
Vanda Pharmaceuticals Inc.1$35
Novo Nordisk Inc1$24
Acella Pharmaceuticals, LLC1$23
Dexcom, Inc.1$22

Products named: CAPLYTA, TRINTELLIX, NURTEC ODT, Auvelity, VRAYLAR, UBRELVY, FANAPT, QULIPTA.

Industry payments across LA — which companies pay providers there.